United Drug joins Irish exodus
United Drug, a dual-listed Irish €630m market capitalisation company, intends to delist from the Irish Stock Exchange in an effort to gain FTSE index inclusion. It follows several other ISE firms dropping their local listings or moving their primary listing location over the last year to find more liquidity.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article:
- ✔ 4,000 annual insights
- ✔ 700+ notes and long-form analyses
- ✔ 4 capital markets databases
- ✔ Daily newsletters across markets and asset classes
- ✔ 2 weekly podcasts